CN107739342A - A kind of method of the diarylamino benzimidazolone derivatives of one-step synthesis 5 - Google Patents

A kind of method of the diarylamino benzimidazolone derivatives of one-step synthesis 5 Download PDF

Info

Publication number
CN107739342A
CN107739342A CN201711225340.4A CN201711225340A CN107739342A CN 107739342 A CN107739342 A CN 107739342A CN 201711225340 A CN201711225340 A CN 201711225340A CN 107739342 A CN107739342 A CN 107739342A
Authority
CN
China
Prior art keywords
diarylamino
compound
step synthesis
benzimidazolone derivatives
copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201711225340.4A
Other languages
Chinese (zh)
Other versions
CN107739342B (en
Inventor
张珉
梁桃源
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN201711225340.4A priority Critical patent/CN107739342B/en
Publication of CN107739342A publication Critical patent/CN107739342A/en
Application granted granted Critical
Publication of CN107739342B publication Critical patent/CN107739342B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Abstract

The invention belongs to technical field of organic synthesis, discloses a kind of method of the diarylamino benzimidazolone derivatives of one-step synthesis 5.In the reactor, add compound 1, compound 2, metallic catalyst, part, oxidant and solvent, 1~24h of stirring reaction at 25~130 DEG C, reaction is cooled to room temperature after terminating, vacuum rotary steam removes solvent and can obtain crude product, and crude by column chromatography purifies to obtain the 5 diarylamino benzimidazolone derivatives;Described compound 1 refers to the compound with formula (1) structure;Described compound 2 refers to the secondary amine or tertiary amine with formula (2) structure, or its corresponding acid salt.The method of the present invention has synthesis step simple, safe operation, advantages of nontoxic raw materials and cheap and easy to get, synthetic method to the advantages of functional group compatibility is good, Atom economy is high.

Description

A kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives
Technical field
The invention belongs to technical field of organic synthesis, and in particular to a kind of one-step synthesis 5- diarylamino benzimidazolones spread out The method of biology.
Background technology
Benzimidazolone is the derivative of benzimidazole C-2 positions oxidation, is mainly used in dye industry.In recent years, it is related Research finds that a series of benzimidazole ketone compounds also show extensive Medical bioactive, as antibacterial, it is antiviral, disappear Inflammation, anti-hypertension, desinsection and (J.B.Wright, Chem.Rev., the 1951,48,397-541 such as antitumor;A.M.Monforte, A.Rao,P.Logoteta,S.Ferro,L.D.Luca,M.L.Barreca,N.Iraci,G.Maga,E.D.Clercq, C.Pannecouque,A.Chimirri,Bioorgan Med Chem.,2008,16,7429-7435.)。
The method that tradition prepares benzimidazolone is former for starting by o-dichlorohenzene, o-phenylenediamine or ortho-nitraniline etc. Material synthesis obtains.(1) using o-dichlorohenzene as raw material:Under the catalysis of copper powder or stannous chloride, o-dichlorohenzene, ammoniacal liquor and carbonic acid Sodium (or sodium acid carbonate, urea, ethylene carbonate) reaction under conditions of 210-215 DEG C, 6.2-7.8MPa prepares benzimidazole Ketone.The advantage of this synthetic method is that raw material is easy to get and cheap, but needs to carry out under high temperature, condition of high voltage, pair is set It is standby to require higher.(2) using o-phenylenediamine as raw material:The carbonylation agent such as o-phenylenediamine and urea, phosgene, carbon monoxide is contracted Close synthesizing benzimidazole ketone.This method is low for equipment requirements, easy to operate, is adapted to industrialized production.But due to phosgene, one The raw materials such as carbonoxide are toxic gases, unfriendly to environment, and technical requirements are higher, are restricted in actual applications.(3) with Ortho-nitraniline is raw material:Main research ortho-nitraniline is from reducing carbonyl reagent carbon monoxide under different catalyst system and catalyzings Reaction.Although these traditional synthetic methods have raw material to be easy to get and cheap advantage, but need in high temperature, high pressure Under the conditions of carry out, it is higher to equipment requirement, while also have that product quality is high, a large amount of waste water are produced in production process, be useless The obvious deficiencies such as slag, environmental pollution be serious.(the synthesis of the big .5- aminobenzimidazoles ketone of Shao Guang and benzimidazoles compound [D] Dalian University of Technology, 2008).
Wherein, 5-Amino-2-benzimidazolinone is the main intermediate of synthesizing benzimidazole ketone structured pigment, with plastics, oil The industries such as ink, coating are developed rapidly, and the demand of benzimidazolone is continuously increased both at home and abroad.Therefore, more excellent benzo is studied Imidazolone synthesis technique is very necessary.(Shen Yongjia benzimidazolone pigments and its application [J] chemical science and technologies market .2001,24 (04):7-11)。
The content of the invention
In place of shortcoming and defect existing for above prior art, it is an object of the invention to provide a kind of one-step synthesis The method of 5- diarylamino benzimidazolone derivatives.
The object of the invention is achieved through the following technical solutions:
A kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives, comprises the following steps:
In the reactor, compound 1, compound 2, metallic catalyst, part, oxidant and solvent are added, 25~130 1~24h of stirring reaction at DEG C, reaction are cooled to room temperature after terminating, vacuum rotary steam removes solvent and can obtain crude product, crude product Purify to obtain the 5- diarylaminos benzimidazolone derivatives through column chromatography;
Described compound 1 refers to the compound with formula (1) structure;Described compound 2 refers to formula (2) structure Secondary amine or tertiary amine, or its corresponding acid salt;
Wherein, R1Represent the methyl of one or more substitutions on aromatic ring, phenyl, methoxyl group, nitro, itrile group, trifluoromethyl, Ester group, halogenic substituent or hydrogen;R2、R3、R4For alkyl that is identical or differing, substitute alkyl or hydrogen, but R2And R3It is asynchronously Hydrogen.
Reaction equation involved by above-mentioned synthetic method is shown below:
The preferred schlenk pipes (history Ranque tube) of described reactor.
The mol ratio of the compound 1 and compound 2 is (1~20):1;It is preferred that 2:1.
Described metallic catalyst is copper acetate, copper sulphate, stannous chloride, copper chloride, copper fluoride, copper fluoride, iodate Mixing more than one or both of cuprous, cuprous bromide, copper bromide, trifluoromethayl sulfonic acid copper.
Described part is containing n-donor ligand, preferably pyridine or pyridine derivate.
Described oxidant is metal oxide, peroxide, have the acid of oxidisability, silver salt and one kind in oxygen or Two or more mixing, wherein the pressure of oxygen used is 1~30 atmospheric pressure.
Described solvent be acetonitrile, tetrahydrofuran, ethanol, tert-pentyl alcohol, isopropanol, isobutanol, N,N-dimethylformamide, Mixing more than one or both of dimethyl sulfoxide (DMSO), toluene, paraxylene, first alcohol and water.
Described column chromatography purification eluent used is petroleum ether:Dichloromethane:The volume ratio of ethyl acetate is (0.5 ~50):(0~20):1 mixed solvent.
The synthetic method of the present invention has the following advantages that and beneficial effect:
The present invention is using diphenylamine compound and two level or tertiary amine as raw material one-step synthesis 5- diarylamino benzimidazoles Ketone derivatives, have simple synthesis step, safe operation, advantages of nontoxic raw materials and cheap and easy to get, synthetic method compatible to functional group Well, the advantages of Atom economy is high.
Brief description of the drawings
Fig. 1 and Fig. 2 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 1;
Fig. 3 and Fig. 4 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 2;
Fig. 5 and Fig. 6 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 3;
Fig. 7 and Fig. 8 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 4;
Fig. 9 and Figure 10 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 5;
Figure 11 and Figure 12 is respectively the hydrogen spectrogram and carbon spectrogram of the products therefrom of embodiment 6.
Embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are unlimited In this.
Embodiment 1
0.5 mM of diphenylamines, 0.25 mM of diethylamine, 0.05 mM of copper chloride are added in schlenk pipes, 0.5 mM of pyridine, 1.5 milliliters of isobutanols, at 100 DEG C, O2Under the conditions of (oxygen pressure used is an atmospheric pressure) stirring it is anti- After answering 12 hours, stop heating and stirring, be cooled to room temperature, vacuum rotary steam removes solvent, then by column chromatographic isolation and purification, obtains To target product, the volume ratio of column chromatography eluent used is 20:5:1 petroleum ether:Dichloromethane:Ethyl acetate mixing is molten Agent, yield 78%.
Respectively as depicted in figs. 1 and 2, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3) δ 7.58-7.48 (m, 4H), 7.37 (t, J=7.1Hz, 1H), 7.20-7.26 (m, 4H), 7.08 (d, J=7.9Hz, 4H), 6.97 (t, J=7.6Hz, 3H), 6.87 (s, 1H), 6.81 (d, J=8.3Hz, 1H), 3.90 (q, J=7.2Hz, 2H), 1.30 (t, J=7.2Hz, 3H).
13C NMR(101MHz,CDCl3)δ153.34,148.28,142.88,134.94,130.24,129.57, 129.29,127.55,126.01,125.91,123.29,122.32,119.51,109.53,106.03,36.14,13.64。
IR(KBr):3058,3033,2974,2929,2855,1712,1592,1491,1400,1276,1234,1192, 1082,1022,754,695,656cm-1
MS(EI,m/z):405[M]+
HRMS(ESI):Calcd.for C27H23N3ONa[M+Na]+:428.1733;found:428.1727.
The structure for inferring products therefrom according to data above is shown below:
Embodiment 2
0.5 mM of diphenylamines, 0.25 mM of N- ethyl isopropylamine, 0.05 mM of chlorine are added in schlenk pipes Change cuprous, 0.5 mM of pyridine, 1.5 milliliters of isobutanols, at 80 DEG C, O2Under the conditions of (oxygen pressure used is an atmospheric pressure) After stirring reaction 16 hours, stop heating and stirring, be cooled to room temperature, vacuum rotary steam removes solvent, then passes through column chromatography for separation Purifying, target product is obtained, the volume ratio of column chromatography eluent used is 20:5:1 petroleum ether:Dichloromethane:Acetic acid second Ester mixed solvent, yield 34%.
Respectively as shown in Figure 3 and Figure 4, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3):δ 7.48-7.55 (m, 4H), 7.37 (t, J=6.7Hz, 1H), 7.23 (d, J= 7.4Hz, 3H), 7.09 (d, J=7.8Hz, 4H), 6.97 (d, J=7.5Hz, 4H), 6.79 (d, J=7.9Hz, 1H), 4.66 (dt, J=13.8,6.9Hz, 1H), 1.49 (d, J=6.9Hz, 6H).
13C NMR(101MHz,CDCl3):δ153.06,148.28,142.54,134.89,129.56,129.43, 129.29,127.59,126.11,123.29,122.32,119.12,109.43,107.38,45.42,20.23。
IR(KBr):3063,3042,2968,2929,2869,1712,1629,1593,1491,1388,1273,1236, 1176,752,695,660cm-1
MS(EI,m/z):419[M]+
HRMS(ESI):Calcd.for C28H25N3ONa[M+Na]+:442.1890;found:442.1888.
Infer that products therefrom obtains structure and is shown below according to data above:
Embodiment 3
0.5 mM of diphenylamines, 0.25 mM of triallylamine, 0.05 mM of trifluoro are added in schlenk pipes Loprazolam copper, 0.5 mM of pyridine, 1.5 milliliters of isobutanols, at 100 DEG C, O2Under the conditions of (oxygen pressure used is one big Air pressure) stirring reaction is after 12 hours, stopping heating and stirring, room temperature, vacuum rotary steam removing solvent are cooled to, then pass through column chromatography Isolate and purify, obtain target product, the volume ratio of column chromatography eluent used is 20:5:1 petroleum ether:Dichloromethane:Second Acetoacetic ester mixed solvent, yield 37%.
Respectively as shown in Figure 5 and Figure 6, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3):δ7.61–7.47(m,4H),7.35–7.41(m,1H),7.19–7.27(m,4H), 7.02–7.11(m,4H),7.02–6.94(m,3H),6.85–6.80(m,2H),5.81–5.93(m,1H),5.12–5.22(m, 2H),4.52–4.41(m,2H)。
13C NMR(101MHz,CDCl3):δ153.42,148.21,142.92,134.93,131.73,130.39, 129.60,129.28,127.62,125.92,123.39,122.39,119.46,118.07,109.51,106.61,43.66。
IR(KBr):3066,3024,2959,2929,2852,1716,1635,1599,1489,1395,1273,1220, 1177,752,696,655cm-1
MS(EI,m/z):417[M]+
HRMS(ESI):Calcd.for C28H23N3ONa[M+Na]+:440.1733;found:440.1729.
Infer that products therefrom obtains structure and is shown below according to data above:
Embodiment 4
0.5 mM of 4- bromines diphenylamines, 0.25 mM of triethylamine, 0.05 mM of chlorination are added in schlenk pipes Copper, 0.5 mM of pyridine, 0.5 mM of di-tert-butyl peroxide (DTBP), 1.5 milliliters of isobutanols, at 100 DEG C, O2Condition Under (oxygen pressure used is an atmospheric pressure) stirring reaction after 12 hours, stop heating and stirring, be cooled to room temperature, decompression rotation Solvent is evaporated off, then by column chromatographic isolation and purification, obtains target product, the volume ratio of column chromatography eluent used is 20: 5:1 petroleum ether:Dichloromethane:Ethyl acetate mixed solvent, yield 75%.
Respectively as shown in Figure 7 and Figure 8, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3):δ 7.64 (d, J=7.2Hz, 2H), 7.44 (d, J=7.3Hz, 2H), 7.31 (d, J =7.4Hz, 2H), 7.24 (d, J=7.4Hz, 2H), 7.07 (d, J=7.9Hz, 2H), 7.04-6.96 (m, 2H), 6.93 (d, J =7.4Hz, 2H), 6.84 (s, 1H), 6.80 (d, J=8.4Hz, 1H), 3.89 (q, J=6.9Hz, 2H), 1.30 (t, J= 6.9Hz,3H)。
13C NMR(101MHz,CDCl3):δ153.02,147.67,147.37,142.64,133.93,132.76, 132.23,130.35,129.48,127.33,125.72,124.36,123.71,123.05,121.05,119.51,114.45, 109.52,106.05,36.22,13.62。
IR(KBr):3039,2959,2925,2852,1708,1638,1490,1403,1307,1232,1072,810, 748,700cm-1
MS(EI,m/z):561[M]+
HRMS(ESI):Calcd.for C27H21Br2N3ONa[M+Na]+:583.9944;found:583.9925.
Infer that products therefrom obtains structure and is shown below according to data above:
Embodiment 5
0.5 mM of diphenylamines, 0.25 mM of two n-hexylamine, 0.05 mM of copper chloride are added in schlenk pipes, 0.5 mM of pyridine, 1.5 milliliters of tert-pentyl alcohols, at 100 DEG C, O2Under the conditions of (oxygen pressure used is an atmospheric pressure) stirring it is anti- After answering 12 hours, stop heating and stirring, be cooled to room temperature, vacuum rotary steam removes solvent, then by column chromatographic isolation and purification, obtains To target product, the volume ratio of column chromatography eluent used is 20:5:1 petroleum ether:Dichloromethane:Ethyl acetate mixing is molten Agent, yield 68%.
Respectively as shown in Figure 9 and Figure 10, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3):δ 7.46-7.60 (m, 4H), 7.32-7.39 (m, 1H), 7.23 (t, J=7.9Hz, 4H), 7.08 (d, J=7.7Hz, 4H), 6.98 (dd, J=11.6,5.4Hz, 3H), 6.86 (d, J=1.8Hz, 1H), 6.80 (dd, J=8.4,2.0Hz, 1H), 3.82 (t, J=7.2Hz, 2H), 1.741.66 (m, 2H), 1.36-1.24 (m, 6H), 0.85 (t, J=6.9Hz, 3H).
13C NMR(101MHz,CDCl3):δ153.58,148.24,142.80,134.96,130.67,129.52, 129.26,127.47,125.90,125.85,123.25,122.29,119.39,109.45,106.20,41.37,31.51, 28.31,26.54,22.55,14.12。
IR(KBr):3066,3033,2953,2928,2857,1715,1626,1594,1490,1398,1370,1274, 1176,1092,753,695,657cm-1
MS(EI,m/z):461[M]+
HRMS(ESI):Calcd.for C31H31N3ONa[M+Na]+:484.2359;found:484.2363.
Infer that products therefrom obtains structure and is shown below according to data above:
Embodiment 6
0.5 mM of 4- methyldiphenylamine, 0.25 mM of diethylamine, 0.05 mM of chlorine are added in schlenk pipes Change copper, 0.5 mM of pyridine, 1.5 milliliters of isobutanols, at 80 DEG C, O2Under the conditions of (oxygen pressure used is an atmospheric pressure) stir After mixing reaction 24 hours, stop heating and stirring, be cooled to room temperature, vacuum rotary steam removes solvent, then pure by column chromatography for separation Change, obtain target product, the volume ratio of column chromatography eluent used is 20:5:1 petroleum ether:Dichloromethane:Ethyl acetate Mixed solvent, yield 59%.
Respectively as is illustrated by figs. 11 and 12, structural characterization data are as follows for the hydrogen spectrogram and carbon spectrogram of products therefrom:
1H NMR(400MHz,CDCl3):δ 7.43-7.39 (m, 2H), 7.30 (d, J=8.1Hz, 2H), 7.23-7.18 (m, 2H), 7.07-6.99 (m, 6H), 6.95-6.91 (m, 2H), 6.85 (d, J=1.8Hz, 1H), 6.78 (dd, J=8.4,1.9Hz, 1H), 3.89 (q, J=7.2Hz, 2H), 2.40 (s, 3H), 2.31 (s, 3H), 1.30 (t, J=7.2Hz, 3H).
13C NMR(101MHz,CDCl3):δ153.45,148.60,145.71,142.96,137.46,132.32, 132.28,130.17,130.15,129.97,129.18,126.04,125.83,124.07,122.55,121.70,119.14, 109.41,105.68,36.10,21.28,20.90,13.68。
IR(KBr):3030,2968,2926,2855,1714,1627,1594,1508,1492,1401,1294,1234, 811,750,696cm-1
MS(EI,m/z):433[M]+
HRMS(ESI):Calcd.for C29H27N3ONa[M+Na]+:456.2046;found:456.2047.
Infer that products therefrom obtains structure and is shown below according to data above:
Above-described embodiment is the preferable embodiment of the present invention, but embodiments of the present invention are not by above-described embodiment Limitation, other any Spirit Essences without departing from the present invention with made under principle change, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.

Claims (9)

  1. A kind of 1. method of one-step synthesis 5- diarylamino benzimidazolone derivatives, it is characterised in that comprise the following steps:
    In the reactor, compound 1, compound 2, metallic catalyst, part, oxidant and solvent are added, at 25~130 DEG C 1~24h of stirring reaction, reaction are cooled to room temperature after terminating, vacuum rotary steam removes solvent and can obtain crude product, and crude product is through post Chromatographic purification obtains the 5- diarylaminos benzimidazolone derivatives;
    Described compound 1 refers to the compound with formula (1) structure;Described compound 2 refers to there is the two of formula (2) structure Level amine or tertiary amine, or its corresponding acid salt;
    Wherein, R1Represent the methyl of one or more substitutions on aromatic ring, phenyl, methoxyl group, nitro, itrile group, trifluoromethyl, ester group, Halogenic substituent or hydrogen;R2、R3、R4For alkyl that is identical or differing, substitute alkyl or hydrogen, but R2And R3It is asynchronously hydrogen.
  2. 2. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described reactor is managed for schlenk.
  3. 3. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:The mol ratio of the compound 1 and compound 2 is (1~20):1.
  4. 4. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described metallic catalyst is copper acetate, copper sulphate, stannous chloride, copper chloride, copper fluoride, copper fluoride, iodate Asia Mixing more than one or both of copper, cuprous bromide, copper bromide, trifluoromethayl sulfonic acid copper.
  5. 5. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described part is containing n-donor ligand.
  6. 6. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 5, its feature It is:Described containing n-donor ligand is pyridine or pyridine derivate.
  7. 7. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described oxidant is metal oxide, peroxide, the acid with oxidisability, silver salt and one kind in oxygen or two The mixing of the kind above, the pressure of the oxygen is 1~30 atmospheric pressure.
  8. 8. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described solvent is acetonitrile, tetrahydrofuran, ethanol, tert-pentyl alcohol, isopropanol, isobutanol, N,N-dimethylformamide, two Mixing more than one or both of methyl sulfoxide, toluene, paraxylene, first alcohol and water.
  9. 9. a kind of method of one-step synthesis 5- diarylamino benzimidazolone derivatives according to claim 1, its feature It is:Described column chromatography purification eluent used is petroleum ether:Dichloromethane:The volume ratio of ethyl acetate for (0.5~ 50):(0~20):1 mixed solvent.
CN201711225340.4A 2017-11-29 2017-11-29 Method for synthesizing 5-diarylaminobenzimidazole ketone derivative in one step Active CN107739342B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711225340.4A CN107739342B (en) 2017-11-29 2017-11-29 Method for synthesizing 5-diarylaminobenzimidazole ketone derivative in one step

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711225340.4A CN107739342B (en) 2017-11-29 2017-11-29 Method for synthesizing 5-diarylaminobenzimidazole ketone derivative in one step

Publications (2)

Publication Number Publication Date
CN107739342A true CN107739342A (en) 2018-02-27
CN107739342B CN107739342B (en) 2020-01-10

Family

ID=61239721

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711225340.4A Active CN107739342B (en) 2017-11-29 2017-11-29 Method for synthesizing 5-diarylaminobenzimidazole ketone derivative in one step

Country Status (1)

Country Link
CN (1) CN107739342B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110790670A (en) * 2019-08-27 2020-02-14 浙江工业大学 Synthesis method of photocatalytic tertiary amine compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101321736A (en) * 2005-09-30 2008-12-10 葛兰素集团有限公司 Compounds which have activity at m1 receptor and their uses in medicine
EP2394997A1 (en) * 2009-02-03 2011-12-14 Mitsubishi Tanabe Pharma Corporation Process for preparing 1-(4-piperidinyl)benzimidazolone derivatives
CN102295605A (en) * 2011-06-22 2011-12-28 华东理工大学 Method for preparing benzimidazolone derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101321736A (en) * 2005-09-30 2008-12-10 葛兰素集团有限公司 Compounds which have activity at m1 receptor and their uses in medicine
EP2394997A1 (en) * 2009-02-03 2011-12-14 Mitsubishi Tanabe Pharma Corporation Process for preparing 1-(4-piperidinyl)benzimidazolone derivatives
CN102295605A (en) * 2011-06-22 2011-12-28 华东理工大学 Method for preparing benzimidazolone derivative

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BO YU ET AL.: "DBU-Based Ionic-Liquid-Catalyzed Carbonylation of o‑Phenylenediamines with CO2 to 2‑Benzimidazolones under Solvent-Free Conditions", 《ACS CATALYSIS》 *
DEEPAK B. ET AL.: "Copper-catalyzed efficient synthesis of a 2-benzimidazolone scaffold from 2-nitroaniline and dimethyl carbonate via a hydrosilylation reaction", 《GREEN CHEMISTRY》 *
TAOYUAN LIANG ET AL.: "Synthesis of Multisubstituted Benzimidazolones via Copper-Catalyzed Oxidative Tandem C–H Aminations and Alkyl Deconstructive Carbofunctionalization", 《ISCIENCE》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110790670A (en) * 2019-08-27 2020-02-14 浙江工业大学 Synthesis method of photocatalytic tertiary amine compound

Also Published As

Publication number Publication date
CN107739342B (en) 2020-01-10

Similar Documents

Publication Publication Date Title
CN107382803B (en) A kind of preparation method of beta-hydroxy phenyl selenide compound
CN108047107B (en) The preparation method of diphenyl disenenide ether compound
CN105801575B (en) A kind of synthetic method of imidazo [1,2-a] pyridine
CN105175328B (en) It is a kind of using aromatic amine, aromatic aldehyde, ketone synthesis of quinoline derivatives method
CN109232310A (en) A kind of trifluoroacetyl group replaces hydazone derivative and its synthetic method
CN110204487A (en) A kind of synthetic method of quinoline
CN108640917A (en) A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound
CN105949147B (en) A kind of method of green syt 2-mercaptobenzothiazole analog derivative
CN107739342A (en) A kind of method of the diarylamino benzimidazolone derivatives of one-step synthesis 5
CN105330540A (en) Preparation method for montelukast sodium intermediate
CN106188040A (en) A kind of Fevipiprant and the preparation method of intermediate thereof
CN106188046B (en) A kind of synthetic method of 3- arylthios imidazo [1,5-a] N- heterocyclic compounds that iodine promotes
CN105732619A (en) Synthesizing method of 5,6,7,8-tetrahydropyridino-[2,3-d]pyrimidine compound
CN105367399B (en) A kind of preparation method of 9,10 luxuriant and rich with fragrance quinones
Zhu et al. Switching reaction pathways of trifluoromethylated thiobenzanilides by choice of different oxidative systems
CN106588921B (en) A kind of synthetic method of the methyl formate of 7 azaindole 3
CN105237337B (en) The synthetic method of new 5 [10 (9 carboxyl anthryl)] M-phthalic acid
CN111269153B (en) Synthetic method of alpha, alpha-difluoro-beta-carbonyl sulfone compound
CN107915663A (en) Copper catalysis protects the synthetic method of ortho-nitrophenyl amine compound
CN106243073B (en) A kind of 2-H 1-benzopyran derivatives and its synthetic method
CN108101755A (en) A kind of method for preparing chiral 4- (2- propargyls) phenol compound
CN107663149A (en) A kind of preparation method of phenanthrenequione and its derivative
CN106083690A (en) A kind of preparation method of polysubstituted 3 methylene indolones
CN105198806A (en) Method for synthesizing quinoline by aromatic amine and diketone
CN107382640A (en) The synthetic method of β aryl phenylpropyl alcohol ketone class compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant